Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Qingfei Dayuan granules for influenza (wind-heat with dampness syndrome)
CTR20244746Phase 2Active
- Sponsor
- Jing Brand Chizhengtang Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing Qingfei Dayuan granules with Placebo (2 arms). Primary endpoint: Clinical cure rate at day 5. Started Jan 2025; status: active.
02
Drugs
Qingfei Dayuan Granule
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20244746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244746.